/Investor DB

Genesys Capital — Full Portfolio

31 tracked investments · listed companies and verified rows first

Profound Medicalprofoundmedical.comin𝕏NASDAQ: PROF

Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.

BiotechDeep TechHealthtechMedical DevicesMississauga

Arun Menawat(CEO and Chairman of the Board)inRashed Dewan(Executive Officer)inMathieu Burtnyk(Chief Operating Officer)inTom Tamberrino(Chief Commercial Officer)

BoardJean-Francois Pariseau(Director)Damian Lamb(Director)

Co-investorsCTI Life Sciences Fund L.P.FACIT (Fight Against Cancer Innovation Trust)

Adapsyn Bioscienceadapsyn.comin✓ verified

Adapsyn Bioscience is a biotech company focused on discovering and developing microbial natural product small molecules for therapeutic applications by leveraging genomic and chemical biology approaches.

AI & Machine LearningBiotechDeep TechHamilton, CA

Nathan Magarvey(Founder)

Co-investorsPfizer Venture Investments

Antegrade Medical Incantegrademedical.com

Antegrade Medical is a Quebec City-based medical device startup developing single-use procedural tools enabling an antegrade approach for structural interventional cardiology procedures.

Crestacresta.comin𝕏Mar 2022

Cresta provides a unified platform combining human and AI agents to automate and augment customer service interactions for enterprise contact centers.

AI & Machine LearningEnterprise SoftwareSaaSSales TechSunnyvale, US

Sebastian Thrun(Founder)inTim Shi(Founder)inZayd Enam(Founder)inAndre Esteva(Founder)inShan Huang(Co-Founder)inPing Wu(Chief Executive Officer)in

Co-investorsAndreessen HorowitzTiger Global ManagementArcherman CapitalBallistic VenturesBrilliant Phoenix CapitalComcast Ventures+17 more

Crestacrestapaints.comMar 2022

Leading paint manufacturer in Ghana focused on West African exports.

Co-investorsAdenia PartnersAccenture VenturesAndreessen HorowitzGreylock PartnersLG Technology VenturesQualcomm Ventures+5 more

Cryostasis Inccryostasis.ca

Cryostasis develops the Woolii SU (Subzero Unfrozen) platform, a preservation system that stores cell therapy products at subzero temperatures without freezing or cryoprotectants.

BiotechDeep TechHardwareHealthtechMedical Devices

Ebt Medicalebtmedical.comin𝕏

EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.

BiotechMedical Devices

Paul Yoo(Co-founder, President & Chief Scientific Officer)inSasha John(Co-founder and Chief Innovation Officer)inKeith R Carlton(Chief Executive Officer)in

Co-investorsSV Health InvestorsToronto Innovation Acceleration Partners

Enspire DBS Therapyenspiredbs.com

Enspire DBS is conducting a clinical trial evaluating Deep Brain Stimulation combined with physical therapy (DBS + Rehab) to assess safety and whether it can improve arm function in stroke patients with lasting impairment.

HealthtechMedical Devices

Co-investorsJobsOhio Ventures

Feldan Therapeuticsfeldan.cominSep 2024

Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.

BiotechDeep TechMedical Devices

François-Thomas Michaud(Board Member & Chief Executive Officer)in

Co-investorsAsahi Kasei Corporate Venture CapitalLinearis VenturesFonds de solidarité FTQZynext Ventures

Flosonics Medicalflosonicsmedical.comin𝕏

Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.

Digital HealthHardwareMedical Devices

Joe Eibl(Founder)in

Co-investorsadMare BioInnovationsAmplify CapitalArboretum VenturesiGan PartnersNew Leaf Venture PartnersRBCx

Fusion Pharmaceuticalsfusionpharma.comin𝕏Apr 2019 · $105M

Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.

BiotechHealthtech

John Valliant(Founder)in

Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesPivotal Life SciencesSeroba Life SciencesVenture Ontario+6 more

IDbyDNAillumina.comJan 2020 · $20MAcquired

Scalable, high throughput DNA sequencing platforms.

Co-investorsARCH Venture PartnersArtis VenturesHemisphere Ventures LLCHeran PartnersSPRINGROCK VENTURESVenrock

Inversagoinversago.comOct 2022acquired by Novo Nordisk

Portfolio company acquired by Novo Nordisk for $1.1B USD.

Co-investorsadMare BioInnovationsAmorChemJDRF T1D FundNew Enterprise Associates (NEA)Tarnagulla VenturesAmgen Ventures+2 more

Invitaeinvitae.comin𝕏Oct 2014 · $120M

Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Sean George(Executive Officer, Director)inRandal Scott(Executive Officer, Director)Shelly Guyer(Executive Officer)inLee Bendekgey(Executive Officer)inGeoffrey Crouse(Director)

BoardEric Aguiar(Director)in

Co-investorsCivilization Ventures Management, LlcDecheng CapitalFifty YearsManta Ray VenturesOberland CapitalPrefix Capital+9 more

Scaled Cognitionscaledcognition.comin𝕏Jul 2026 · $100M

Scaled Cognition builds enterprise AI models designed for reliability and deterministic execution in mission-critical workflows, delivering the same correct answer consistently across repeated scenarios.

AI & Machine LearningEnterprise SoftwareSaaSMountain View, US

Dan Roth(Co-Founder & CEO)inDan Klein(Co-Founder & CTO)inDamon Pender(Co-Founder & CFO)in

Co-investorsLerer HippeauOwl VenturesKhosla Ventures

Seroba Life Sciencesseroba-lifesciences.cominApr 2019 · $105M

This page is a news post from Azafaros, a biopharmaceutical company developing disease-modifying therapeutics for lysosomal storage disorders with a focus on neurological symptoms.

Biotech

Co-investorsCDP Venture CapitalIreland Strategic Investment FundAdams Street PartnersHealthCapOrbiMedPivotal Life Sciences+1 more

Veraloxveralox.comJun 2021acquired by Cadrenal Therapeutics · Dec 2025 · $200K

Developing novel treatments based on the 12-LOX pathway for immuno-inflammatory diseases.

Co-investorsAlumni VenturesHatteras Venture PartnersPappas CapitalSanofi VenturesAlexandriaJDRF T1D Fund+4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AptinyxBios GenomicsDelexEpocalFairhaven PharmaceuticalsFunction NeuromodulationFusionGiiantGiiant Pharma IncIonalyticsMillenniumQuestat IncVeralox Therapeutics Inc

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.